Peptide record

TPDB09559

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09559
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 20-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
IIGAIAAALPHVINAIKNTF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C96H159N25O24
RDCEQMSWY
AI
2047.47
10.10
2
0
13
+1
-1.02
1.275
156.50
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
3
Residue Composition
number
5
A
0
R
2
N
0
D
0
C
0
E
0
Q
1
G
1
H
5
I
1
L
1
K
0
M
1
F
1
P
0
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 5 R: 0 N: 2 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 1 I: 5 L: 1 K: 1 M: 0 F: 1 P: 1 S: 0 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
20 reviewed residue count
C96H159N25O24 sequence-only estimate (linear, free termini)
2047.47 sequence-only estimate (linear, free termini)
10.10 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-1.02 sequence-only estimate (linear, free termini)
1.275 sequence-only estimate (linear, free termini)
Evidence Records 9 records
Evidence 1 Activity

Activity

Antibacterial

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against S. aureus.
Evidence 2 Activity

Activity

Antifungal

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against S. aureus.
Evidence 3 Activity

Activity

Antiparasitic

Source & Reference

DRAMP

Other

Active against S. aureus.
Evidence 4 Activity

Activity

Antiviral

Source & Reference

DRAMP

Other

Active against S. aureus.
Evidence 5 Activity

Activity

% Hemolysis
Hemolysis
18 50 %
[Ref:19427345]18% hemolytic activity at 16 µM, 45–50% hemolytic activity at 120 µM against horse erythrocytes

Target

horse erythrocytes

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Peptides. 2009 Aug 30(8):1428-1433.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 6 Activity

Activity

50% Hemolysis
Toxicity
120 µM
Hemolytic Cytotoxic
50% Hemolysis | 120 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata. | Peptides | 2009
Evidence 7 Activity

Activity

18% Hemolysis
Toxicity
16 µM
Hemolytic Cytotoxic
18% Hemolysis | 16 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
A family of kassinatuerin-2 related peptides from the skin secretion of the African hyperoliid frog, Kassina maculata. | Peptides | 2009
Evidence 8 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:19427345]18% hemolytic activity at 16 µM, 45–50% hemolytic activity at 120 µM against horse erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
Peptides. 2009 Aug 30(8):1428-1433.
Evidence 9 Hemolysis

Activity

18 50 %
% Hemolysis
[Ref:19427345]18% hemolytic activity at 16 µM, 45–50% hemolytic activity at 120 µM against horse erythrocytes
Hemolysis

Target

horse erythrocytes

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
Peptides. 2009 Aug 30(8):1428-1433.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.